DRUG NEWS: GI drug gets stiff new warning

July 2004 
Volume 34  Number 7
Pages 27 - 27
  PDF Version Available!

© 2004 Lippincott Williams & Wilkins, Inc. Volume 34(7)             July 2004             p 27 GI drug gets stiff new warning [DRUG NEWS: IRRITABLE BOWEL SYNDROME]

Indicated for irritable bowel syndrome, Zelnorm (tegaserod) will now carry new labeling to warn about a serious potential adverse reaction: diarrhea severe enough to require hospitalization. The new labeling also warns about the possibility of reduced blood flow to the intestines, an adverse reaction reported in over 20 people using Zelnorm. Three of these patients needed surgery and four died. However, whether Zelnorm was responsible for the ischemia is unclear.

Because the drug's benefits outweigh its risks, it will remain on the market, according to the director of the FDA's gastrointestinal (GI) drug division. But patients taking Zelnorm should stop taking it immediately and call their health care provider if they experience ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

Featured Jobs

Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member